74 related articles for article (PubMed ID: 16673494)
21. Focus on hepatitis. Final APRICOT, ACTG A5071 results.
Highleyman L
IAPAC Mon; 2004 Sep; 10(9):356-7. PubMed ID: 15801102
[No Abstract] [Full Text] [Related]
22. Detection of hepatitis C virus RNA in normal cervical smears.
Wang C; Polyak SJ; Corey L
Clin Infect Dis; 2003 Jul; 37(2):314; author reply 314-5. PubMed ID: 12856226
[No Abstract] [Full Text] [Related]
23. Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients.
Filippini P; Coppola N; Pisapia R; Martini S; Marrocco C; Di Martino F; Sagnelli C; Filippini A; Sagnelli E
J Med Virol; 2007 Nov; 79(11):1679-85. PubMed ID: 17854026
[TBL] [Abstract][Full Text] [Related]
24. Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population.
Reiche EM; Bonametti AM; Morimoto HK; Morimoto AA; Wiechemann SL; Matsuo T; Vissoci Reiche F; Vogler IH
Int J Mol Med; 2008 Mar; 21(3):387-95. PubMed ID: 18288387
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV.
Letendre S; Paulino AD; Rockenstein E; Adame A; Crews L; Cherner M; Heaton R; Ellis R; Everall IP; Grant I; Masliah E;
J Infect Dis; 2007 Aug; 196(3):361-70. PubMed ID: 17597450
[TBL] [Abstract][Full Text] [Related]
26. [Biotechnology applied to the diagnosis of HIV/hepatitis C co-infection].
Maroto Vela MC
An R Acad Nac Med (Madr); 1996; 113(3):643-55; discussion 655-8. PubMed ID: 9124648
[No Abstract] [Full Text] [Related]
27. Evaluation of circulating natural type 1 interferon-producing cells in HIV/GBV-C and HIV/HCV coinfected patients: a preliminary study.
Haji Molla Hoseini M; Pourfathollah AA; Mohraz M; Soheili Z; Amini S; Aghaiepour M; Samiee S; Nikoogoftar M; Meshkani R
Arch Med Res; 2007 Nov; 38(8):868-75. PubMed ID: 17923269
[TBL] [Abstract][Full Text] [Related]
28. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
[TBL] [Abstract][Full Text] [Related]
29. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic.
Urbanus AT; van de Laar TJ; Stolte IG; Schinkel J; Heijman T; Coutinho RA; Prins M
AIDS; 2009 Jul; 23(12):F1-7. PubMed ID: 19542864
[TBL] [Abstract][Full Text] [Related]
31. Analysis of sequence configurations of the PKR-interacting HCV proteins from plasma and PBMC as predictors of response to interferon-alpha and ribavirin therapy in HIV-coinfected patients.
Bolcic F; Bull L; Martinez L; Reynoso R; Salomon H; Arduino R; Barnett B; Quarleri J
Intervirology; 2008; 51(4):261-4. PubMed ID: 18824873
[No Abstract] [Full Text] [Related]
32. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland.
Chlabicz S; Flisiak R; Kowalczuk O; Wiercińska-Drapalo A; Pytel-Krolczuk B; Prokopowicz D; Chyczewski L
J Med Virol; 2008 Apr; 80(4):615-8. PubMed ID: 18297715
[TBL] [Abstract][Full Text] [Related]
34. Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV.
Roe B; Coughlan S; Hassan J; Grogan A; Farrell G; Norris S; Bergin C; Hall WW
J Infect Dis; 2007 Oct; 196(7):1053-7. PubMed ID: 17763328
[TBL] [Abstract][Full Text] [Related]
35. GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.
Berzsenyi MD; Bowden DS; Roberts SK; Revill PA
J Gastroenterol Hepatol; 2009 Aug; 24(8):1407-10. PubMed ID: 19702909
[TBL] [Abstract][Full Text] [Related]
36. Repeated HCV-clearance in an HIV-infected patient.
Vogel M; Wasmuth JC; Rockstroh JK; Holm S; Kuhlmann B
Infection; 2007 Apr; 35(2):120-1. PubMed ID: 17401720
[No Abstract] [Full Text] [Related]
37. Treatment of hepatitis C virus in human immunodeficiency virus infected patients in "real life": modifications in two large surveys between 2004 and 2006.
Cacoub P; Halfon P; Rosenthal E; Pialoux G; Benhamou Y; Perronne C; Pol S;
J Hepatol; 2008 Jan; 48(1):35-42. PubMed ID: 17945375
[TBL] [Abstract][Full Text] [Related]
38. Impact of HIV on host-virus interactions during early hepatitis C virus infection.
Danta M; Semmo N; Fabris P; Brown D; Pybus OG; Sabin CA; Bhagani S; Emery VC; Dusheiko GM; Klenerman P
J Infect Dis; 2008 Jun; 197(11):1558-66. PubMed ID: 18419344
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus reinfection in injection drug users.
Grebely J; Conway B; Raffa JD; Lai C; Krajden M; Tyndall MW
Hepatology; 2006 Nov; 44(5):1139-45. PubMed ID: 17058216
[TBL] [Abstract][Full Text] [Related]
40. Spontaneous clearance of hepatitis C virus after liver transplantation in two patients coinfected with hepatitis C virus and human immunodeficiency virus.
Bhagat V; Foont JA; Schiff ER; Regev A
Liver Transpl; 2008 Jan; 14(1):92-5. PubMed ID: 18161776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
